Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
AR101 Oral Immunotherapy for Peanut AllergyThe New England journal of medicine, 2018-11, Vol.379 (21), p.1991-2001 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1812856 ;PMID: 30449234Full text available |
|
2 |
Material Type: Article
|
Harnessing the anti-cancer natural product nimbolide for targeted protein degradationNature chemical biology, 2019-07, Vol.15 (7), p.747-755 [Peer Reviewed Journal]Copyright Nature Publishing Group Jul 2019 ;ISSN: 1552-4450 ;EISSN: 1552-4469 ;DOI: 10.1038/s41589-019-0304-8 ;PMID: 31209351Full text available |
|
3 |
Material Type: Article
|
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registriesRheumatology, 2021-02, Vol.60 (2), p.820-828 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1462-0324 ;ISSN: 1462-0332 ;EISSN: 1462-0332 ;EISSN: 1460-2172 ;DOI: 10.1093/rheumatology/keaa393 ;PMID: 32810263Full text available |
|
4 |
Material Type: Article
|
A new antibiotic kills pathogens without detectable resistanceNature (London), 2015-01, Vol.517 (7535), p.455-459 [Peer Reviewed Journal]COPYRIGHT 2015 Nature Publishing Group ;COPYRIGHT 2015 Nature Publishing Group ;Copyright Nature Publishing Group Jan 22, 2015 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature14098 ;PMID: 25561178 ;CODEN: NATUASFull text available |
|
5 |
Material Type: Article
|
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trialThe lancet oncology, 2022-01, Vol.23 (1), p.91-103 [Peer Reviewed Journal]2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1470-2045 ;ISSN: 1474-5488 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00591-X ;PMID: 34895487Full text available |
|
6 |
Material Type: Article
|
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell LymphomaThe New England journal of medicine, 2022-02, Vol.386 (7), p.640-654 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2116133 ;PMID: 34891224Full text available |
|
7 |
Material Type: Article
|
B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologicsAnnals of the rheumatic diseases, 2022-01, Vol.81 (1), p.143-145 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage? ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2021-220549 ;PMID: 34556483Full text available |
|
8 |
Material Type: Article
|
Asymmetric spiroacetalization catalysed by confined Bronsted acidsNature (London), 2012-03, Vol.483 (7389), p.315-319 [Peer Reviewed Journal]2015 INIST-CNRS ;2012 Macmillan Publishers Limited. All rights reserved ;COPYRIGHT 2012 Nature Publishing Group ;COPYRIGHT 2012 Nature Publishing Group ;Copyright Nature Publishing Group Mar 15, 2012 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature10932 ;PMID: 22422266 ;CODEN: NATUASFull text available |
|
9 |
Material Type: Article
|
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort StudyAmerican journal of clinical dermatology, 2021-07, Vol.22 (4), p.567-579 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021 ;Copyright Springer Nature B.V. Jul 2021 ;ISSN: 1175-0561 ;EISSN: 1179-1888 ;DOI: 10.1007/s40257-021-00598-4 ;PMID: 33786754Full text available |
|
10 |
Material Type: Article
|
Spider Silk: From Soluble Protein to Extraordinary FiberAngewandte Chemie (International ed.), 2009-05, Vol.48 (20), p.3584-3596 [Peer Reviewed Journal]Copyright © 2009 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim ;ISSN: 1433-7851 ;EISSN: 1521-3773 ;DOI: 10.1002/anie.200803341 ;PMID: 19212993Full text available |
|
11 |
Material Type: Article
|
Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn’s diseaseAlimentary pharmacology & therapeutics, 2020-06, Vol.51 (11), p.1031-1038 [Peer Reviewed Journal]2020 John Wiley & Sons Ltd ;2020 John Wiley & Sons Ltd. ;Copyright © 2020 John Wiley & Sons Ltd ;ISSN: 0269-2813 ;EISSN: 1365-2036 ;DOI: 10.1111/apt.15719 ;PMID: 32329532Full text available |
|
12 |
Material Type: Article
|
Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid ArthritisAnnals of the rheumatic diseases, 2018-06, Vol.77 (6), p.905-910 [Peer Reviewed Journal]Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;Copyright: 2018 © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2017-212825 ;PMID: 29592917Full text available |
|
13 |
Material Type: Article
|
Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New YorkThe New England journal of medicine, 2020-07, Vol.383 (1), p.85-88 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2009567 ;PMID: 32348641Full text available |
|
14 |
Material Type: Article
|
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactationAnnals of the rheumatic diseases, 2016-05, Vol.75 (5), p.795-810 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2015-208840 ;PMID: 26888948 ;CODEN: ARDIAOFull text available |
|
15 |
Material Type: Article
|
Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable MelanomaJournal of clinical oncology, 2018-06, Vol.36 (17), p.1658-1667 [Peer Reviewed Journal]2017 by American Society of Clinical Oncology 2017 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.73.7379 ;PMID: 28981385Full text available |
|
16 |
Material Type: Article
|
Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?Annals of the rheumatic diseases, 2011-11, Vol.70 (11), p.1914-1920 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2015 INIST-CNRS ;Copyright: 2011 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2011 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard.2011.151043 ;PMID: 21791449 ;CODEN: ARDIAOFull text available |
|
17 |
Material Type: Article
|
Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and RheumatologistsBioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2017-10, Vol.31 (5), p.447-459 [Peer Reviewed Journal]Springer International Publishing AG 2017 ;Copyright Springer Science & Business Media Oct 2017 ;ISSN: 1173-8804 ;EISSN: 1179-190X ;DOI: 10.1007/s40259-017-0244-3 ;PMID: 28929342Full text available |
|
18 |
Material Type: Article
|
Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional TrialJournal of clinical oncology, 2021-09, Vol.39 (27), p.3034-3043 [Peer Reviewed Journal]2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.00377 ;PMID: 34133196Full text available |
|
19 |
Material Type: Article
|
Human Gut Commensal Membrane Vesicles Modulate Inflammation by Generating M2-like Macrophages and Myeloid-Derived Suppressor CellsThe Journal of immunology (1950), 2020-11, Vol.205 (10), p.2707-2718 [Peer Reviewed Journal]Copyright © 2020 by The American Association of Immunologists, Inc. ;ISSN: 0022-1767 ;EISSN: 1550-6606 ;DOI: 10.4049/jimmunol.2000731 ;PMID: 33028617Full text available |
|
20 |
Material Type: Article
|
Implementation of CT-P13 via a Managed Switch Programme in Crohn’s Disease: 12-Month Real-World OutcomesDigestive diseases and sciences, 2019-06, Vol.64 (6), p.1660-1667 [Peer Reviewed Journal]Springer Science+Business Media, LLC, part of Springer Nature 2018 ;COPYRIGHT 2019 Springer ;Digestive Diseases and Sciences is a copyright of Springer, (2018). All Rights Reserved. ;Springer Science+Business Media, LLC, part of Springer Nature 2018. ;ISSN: 0163-2116 ;EISSN: 1573-2568 ;DOI: 10.1007/s10620-018-5406-8 ;PMID: 30535885Full text available |